Information for the Public: Activities of the SPORE Program
Funding Information, Reports, and Announcements
SPORE Annual Workshop
- 15th Annual SPORE Investigators' Workshop: July 7-10, 2007
Baltimore Marriott Waterfront
| |
Back to Top |
Updated fall of 2007 |
New SPOREs*
|
2007 |
|
SPORE |
Institution |
|
Gastrointestinal |
Dana-Farber Harvard Cancer Center
SPORE Director: Charles Fuchs, M.D., M.P.H. |
|
Head and Neck |
Emory University
SPORE Director: Dong Shin, M.D. |
|
Lymphoma |
Baylor College of Medicine
SPORE Director: Helen Heslop, M.D. |
*Includes only new grants
Back to Top
Co-Funding & Partnerships
Co-Funding of SPOREs
The AVON-NCI Progress for Patients (PFP) Awards Program
In 2002, the Avon Foundation (AVON) and the National Institutes of Health (NIH) National Cancer Institute (NCI) announced the AVON-NCI Progress for Patients (PFP) Awards Program, a special private-public partnership to fund innovative research for preventing, detecting, diagnosing, and treating breast cancer. The objectives of the AVON-NCI PFP are to reduce time delays in performing early phase clinical trials, pilot, and validation studies as well as increase pipeline of agents/analyses/tests for Phase III trials. Moreover, AVON pledged $30 million to fund breast cancer research over 5 years through a limited competition involving institutions with NCI Cancer Center Support and Specialized Programs of Research Excellence (SPORE) grants. The NCI will continue to contribute funds, conduct peer reviews, and monitor project progress. Please be aware that the Program Announcement can be found at http://grants.nih.gov/grants/guide/pa-files/PAR-07-245.html and contains specific instructions that were added in 2007.
Additionally, it is important to note that the guidelines from previous years have been modified to include the following *NEW* requirements:
- Each competitive supplement application should be submitted by the Principal Investigator of the parent P50 grant
- Avon-NCI PFP applications will not be accepted when the proposed funding period extends beyond the end date of the parent P50 5-year project period
- If investigators from other SPOREs/Cancer Centers are included in the application as subcontractors, the funding period of these subcontractors should not exceed their respective parent P50/P30 project period
- Previously unfunded, revised projects must be resubmitted as new rather amended applications
Back to Top
OSB-sponsored Workshops and Meetings
Current and Previous Program Announcements
Archived Announcements and Information
For our guests, who are navigating our website, we have created a user friendly dictionary to further assist you. The following terms and acronyms are commonly used in the SPORE website as well as the NCI. They are commonly used in the SPORE Guidelines, Program Announcements, and other science related materials inherent to the NCI and NIH.
Frequently Used Terms Back to Top
|
